Literature DB >> 200792

Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia.

J R Patsch, R L Jackson, A M Gotto.   

Abstract

Familial type III hyperlipoproteinemia is characterized by the presence of elevated plasma levels of very low density lopoproteins (VLDL) which contain an increased amount of cholesterol and by the presence of a significant amount of lipoproteins with an intermediate density between that of VLDL and low density lipoproteins (LDL); the intermediate density lopoproteins, designated IDL or Lp III, have a slower electrophoretic migration rate than VLDL, and are found in the ultracentrifugal top fraction as a contaminant. Classically, the diagnosis of type III is based on the demonstration of beta-migrating lipoproteins in the ultracentrifugal top fraction (density less than 1.006), thus "floating beta-lipoprotein". More recently, it has been proposed that an elevated VLDL-cholesterol to triglyceride ratio is diagnostic of the disorder. In the present report, we have compared the two methods for their diagnostic value and have concluded that the chemical index definition is the more reliable method for the diagnosis of type III hyperlipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200792     DOI: 10.1007/bf01489475

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  24 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Broad-beta disease (type III hyperlipoproteinemia) in a large kindred. Evidence for a monogenic mechanism.

Authors:  W R Hazzard; T F O'Donnell; Y L Lee
Journal:  Ann Intern Med       Date:  1975-02       Impact factor: 25.391

3.  The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.

Authors:  J Morganroth; R I Levy; D S Fredrickson
Journal:  Ann Intern Med       Date:  1975-02       Impact factor: 25.391

4.  An apolipoprotein preferentially enriched in cholesteryl ester-rich very low density lipoproteins.

Authors:  B Shore; V Shore
Journal:  Biochem Biophys Res Commun       Date:  1974-05-07       Impact factor: 3.575

5.  An electrophoretic method for the quantitative isolation of human and swine plasma lipoproteins.

Authors:  R W Mahley; K H Weisgraber
Journal:  Biochemistry       Date:  1974-04-23       Impact factor: 3.162

6.  Very low density lipoprotein subfractions in a subject with broad-beta disease (Type 3 hyperlipoproteinemia) and a subject with endogenous lipemia (Type IV). Chemical composition and electrophoretic mobility.

Authors:  W R Hazzard; F T Lindgren; E L Bierman
Journal:  Biochim Biophys Acta       Date:  1970-05-05

7.  Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.

Authors:  B Vessby; L A Carlson
Journal:  Eur J Clin Invest       Date:  1975-07-29       Impact factor: 4.686

8.  Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.

Authors:  R J Havel; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

9.  Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).

Authors:  W R Hazzard; E L Bierman
Journal:  Metabolism       Date:  1976-07       Impact factor: 8.694

10.  On thelipoprotein abnormality in type 3 hyperlipoproteinemia.

Authors:  S Quarfordt; R I Levy; D S Fredrickson
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more
  3 in total

Review 1.  Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease.

Authors:  Alan Chait; Henry N Ginsberg; Tomas Vaisar; Jay W Heinecke; Ira J Goldberg; Karin E Bornfeldt
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

2.  Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.

Authors:  Paul N Hopkins; M Nazeem Nanjee; Lily L Wu; Michael G McGinty; Eliot A Brinton; Steven C Hunt; Jeffrey L Anderson
Journal:  Atherosclerosis       Date:  2009-05-22       Impact factor: 5.162

3.  Correlation between Cholesterol, Triglycerides, Calculated, and Measured Lipoproteins: Whether Calculated Small Density Lipoprotein Fraction Predicts Cardiovascular Risks.

Authors:  Sikandar Hayat Khan; Nadeem Fazal; Athar Abbas Gilani Shah; Syed Mohsin Manzoor; Naveed Asif; Aamir Ijaz; Najmusaqib Khan Niazi; Muhammad Yasir
Journal:  J Lipids       Date:  2017-11-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.